Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05716295
What this trial is testing

A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Medikine, Inc. 26
Not applicableUnknownNCT06536725
What this trial is testing

Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral Metastasis

Who this might be right for
Prostate CancerOrganoid
Tianjin Medical University Second Hospital 35
Not applicableEnded earlyNCT01981109
What this trial is testing

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate Cancer
Dendreon 225
Early research (Phase 1)Looking for participantsNCT06942104
What this trial is testing

Imaging of Solid Tumors Using 18F-TRX

Who this might be right for
Solid TumorSolid CarcinomaCastration-Resistant Prostate Carcinoma+7 more
Rahul Aggarwal 56
Large-scale testing (Phase 3)Looking for participantsNCT07831824
What this trial is testing

Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])

Who this might be right for
Prostate Cancer
Lantheus Medical Imaging 408
Not applicableEnded earlyNCT01654068
What this trial is testing

Conformal High Dose Intensity Modulated Radiation Therapy for Disease to Thoracic and Lumbar Spine

Who this might be right for
Vertebral Metastasis
Ronald McGarry 14
Large-scale testing (Phase 3)Study completedNCT01322490
What this trial is testing

A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Bavarian Nordic 1,297
Not applicableLooking for participantsNCT07112599
What this trial is testing

Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics Analysis

Who this might be right for
Prostate CancerLymph Node Cancer MetastaticArtificial Intelligence (AI)
Anhui Medical University 2,000
Post-approval studies (Phase 4)Study completedNCT00242554
What this trial is testing

Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05896371
What this trial is testing

Personalized PSMA Radiopharmaceutical Therapy

Who this might be right for
CancerProstate CancerMetastatic Cancer+1 more
CHU de Quebec-Universite Laval 500
Large-scale testing (Phase 3)Study completedNCT02111577
What this trial is testing

Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
SOTIO a.s. 1,182
Testing effectiveness (Phase 2)Study completedNCT00936975
What this trial is testing

Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 18
Post-approval studies (Phase 4)Active Not RecruitingNCT04549207
What this trial is testing

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

Who this might be right for
Breast CancerCastration-resistant Prostate Cancer
Ottawa Hospital Research Institute 240
Testing effectiveness (Phase 2)Study completedNCT03939689
What this trial is testing

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate CancerProstatic Neoplasm+2 more
Progenics Pharmaceuticals, Inc. 120
Not applicableStudy completedNCT00733213
What this trial is testing

Depiction of Prostate Cancer Treatment Alternatives in Greece

Who this might be right for
Locally Advanced or Metastatic Prostate Cancer.
AstraZeneca 310
Large-scale testing (Phase 3)Study completedNCT00002503
What this trial is testing

Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 204
Not applicableUnknownNCT05252806
What this trial is testing

Quantitative mpMRI to Predict Metastatic Potential of Prostate Cancer

Who this might be right for
Prostate Cancer
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00106418
What this trial is testing

A Research Study for Patients With Prostate Cancer

Who this might be right for
Prostate CancerMetastases
Celgene 35
Not applicableStudy completedNCT05533515
What this trial is testing

Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer

Who this might be right for
Prostate Cancer
Queen Mary University of London 330
Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Next Page